首页> 外文期刊>Journal of Anaesthesiology Clinical Pharmacology >Dexmedetomidine with propofol versus fentanyl with propofol for insertion of Proseal laryngeal mask airway: A randomized, double-blinded clinical trial
【24h】

Dexmedetomidine with propofol versus fentanyl with propofol for insertion of Proseal laryngeal mask airway: A randomized, double-blinded clinical trial

机译:右美托咪定联合丙泊酚与芬太尼联合丙泊酚用于插入前喉喉罩气道:一项随机,双盲临床试验

获取原文
       

摘要

Background and Aims: Successful insertion of the proseal laryngeal mask airway (PLMA) requires much greater doses of propofol as compared to classic laryngeal mask (CLMA). Dexmedetomidine and fentanyl are equally effective adjuvants for CLMA insertion. We designed this study to compare the efficacy of these two drugs as sole adjuvant in PLMA insertion. Material and Methods: Seventy four American Society of Anesthesiologists (ASA) I and II patients were randomly allocated to receive either dexmedetomidine 1 μg/kg [Group PD] or fentanyl 1 μg/kg [Group PF]. Study drugs were diluted in 10 ml NS and administered over 10 min prior to induction of anesthesia with 2.5 mg/kg propofol. PLMA insertion condition was measured according to the Muzi scoring system. Score ≤2 was considered optimal for PLMA insertion. Patient's cardio-respiratory parameters, emergence time, and postoperative pain were also recorded. Results: In our study 83.8% patients in the group PF and 91.9% in the group PD achieved optimal insertion condition (not significant). Hemodynamic stability was maintained in both the groups but the incidence of apnea was significantly higher in the PF group (P = 0.011). We also observed that emergence time was prolonged but postoperative pain scores were significantly lower in the PD group (P 0.001). Conclusion: We conclude that both dexmedetomidine and fentanyl in a dose of 1 μg/kg when used before induction with propofol provide comparable conditions for successful PLMA insertion. Dexmedetomidine has additional advantage of preserving spontaneous respiration and providing better analgesia.
机译:背景与目的:与经典喉罩(CLMA)相比,成功插入前列腺喉罩气道(PLMA)所需的异丙酚剂量要大得多。右美托咪定和芬太尼对于CLMA插入同样有效。我们设计了这项研究,以比较这两种药物在PLMA插入中作为唯一佐剂的功效。材料和方法:74位美国麻醉医师学会(ASA)I和II患者被随机分配接受右美托咪定1μg/ kg [PD组]或芬太尼1μg/ kg [PF组]。将研究药物稀释在10 ml NS中,并在用2.5 mg / kg异丙酚诱导麻醉之前,在10分钟内给药。根据Muzi评分系统测量PLMA插入条件。分数≤2被认为是插入PLMA的最佳选择。还记录了患者的心脏呼吸参数,出现时间和术后疼痛。结果:在我们的研究中,PF组中83.8%的患者和PD组中91.9%的患者达到了最佳插入条件(无显着性)。两组均保持了血流动力学稳定性,但PF组的呼吸暂停发生率明显更高(P = 0.011)。我们还观察到PD组的出苗时间延长,但术后疼痛评分明显降低(P <0.001)。结论:我们得出的结论是,异丙酚诱导前使用右美托咪定和芬太尼的剂量均为1μg/ kg,可为成功插入PLMA提供可比的条件。右美托咪定具有保持自发呼吸和提供更好的镇痛作用的其他优点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号